Skip to main content
padlock icon - secure page this page is secure

Quantitative Sequence-Activity Model (QSAM): Applying QSAR Strategy to Model and Predict Bioactivity and Function of Peptides, Proteins and Nucleic Acids

Buy Article:

$68.00 + tax (Refund Policy)

Traditional quantitative structure-activity relationship (QSAR) is a term describing a variety of approaches that are of substantial interest for chemistry. Quantitative sequence-activity model (QSAM), applying QSAR strategy to explore sequence-activity/function relationship for biosystems, is greatly meaningful but meanwhile extremely difficult. For biomolecules, high molecular weight, diverse structural morphology and intricate interaction network all bring in traditional QSAR methodologies unprecedented challenges. This article comprehensively reviewed developing process, current state and future perspective of QSAM, concerning its applications into fields of pharmacy, food science, immunology and molecular biology. Besides, discipline-crossing and amalgamation of QSAM with QSAR, bioinformatics and computational biology were also discussed.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: QSAM; QSAR; biosequence; statistical modeling; structural characterization

Document Type: Research Article

Publication date: December 1, 2008

More about this publication?
  • Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more